General Information of the Compound
Compound ID
CP0401607
Compound Name
2-(4-Pyrimidin-2-yl-piperazin-1-ylmethyl)-1H-benzoimidazole
    Show/Hide
Structure
Formula
C16H18N6
Molecular Weight
294.362
Canonical SMILES
C(N1CCN(CC1)c1ncccn1)c1nc2ccccc2[nH]1
    Show/Hide
InChI
InChI=1S/C16H18N6/c1-2-5-14-13(4-1)19-15(20-14)12-21-8-10-22(11-9-21)16-17-6-3-7-18-16/h1-7H,8-12H2,(H,19,20)
    Show/Hide
InChIKey
XJHRQPODSUYKOJ-UHFFFAOYSA-N
Physicochemical Property
logP
1.6751
Rotatable Bonds
3
Heavy Atom Count
22
Polar Areas
60.94
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9922161
SID: 14893795
ChEMBL ID
CHEMBL126595
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 44.8 nM
   TI
   LI
   LO
   TS